133 related articles for article (PubMed ID: 7295339)
1. Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
Berge RK; Bakke OM
Biochem Pharmacol; 1981 Aug; 30(16):2251-6. PubMed ID: 7295339
[No Abstract] [Full Text] [Related]
2. Lipid-metabolizing enzymes, CoASH and long-chain acyl-CoA in rat liver after treatment with tiadenol, nicotinic acid and niadenate.
Bakke OM; Berge RK
Biochem Pharmacol; 1982 Dec; 31(23):3930-3. PubMed ID: 7159471
[No Abstract] [Full Text] [Related]
3. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats and hamsters. I. Comparative action of clofibrate and tiadenol on hepatic and intestinal biosynthesis of cholesterol in hamsters and rats].
Rousselet F; Fredj G; Clenet M
Ann Pharm Fr; 1986; 44(4):269-76. PubMed ID: 3566092
[No Abstract] [Full Text] [Related]
4. Effects of clofibrate and tiadenol on the elimination of lipids and bile acids in rat bile.
Cuchet P; Morrier C; Cand F; Keriel C
Lipids; 1981 Oct; 16(10):732-8. PubMed ID: 7300592
[TBL] [Abstract][Full Text] [Related]
5. Action of tiadenol and clofibrate on biliary excretions of cholesterol and bile salts in rats.
Fredj G; Clenet M; Cuchet P; Rousselet F; Rozé C
Digestion; 1979; 19(4):228-36. PubMed ID: 478204
[TBL] [Abstract][Full Text] [Related]
6. Antilipolytic effect of tiadenol and clofibrate in rat epididymal fat pads.
Bacciarelli C; Boni P; Castellucci A
Farmaco Prat; 1978 Sep; 33(9):401-6. PubMed ID: 218836
[No Abstract] [Full Text] [Related]
7. The effects of tiadenol, clofibrate and clofibride on bile composition in the rat.
Rozé C; Cuchet P; Souchard M; Vaille C; Debray C
Eur J Pharmacol; 1977 May; 43(1):57-64. PubMed ID: 862664
[TBL] [Abstract][Full Text] [Related]
8. [The action of tiadenol on compensatory hypertrophy of the liver in the rat].
Rozé C; Vaille C; Souchard M; De la Tour J; Debray C
Arch Int Pharmacodyn Ther; 1976 Jul; 222(1):166-76. PubMed ID: 984967
[TBL] [Abstract][Full Text] [Related]
9. [Comparative effects of clofibrate and tiadenol on the metabolism of cholesterol in rats. II. Comparative action of clofibrate and tiadenol on biliary and fecal excretion of cholesterol and its metabolites in rats].
Fredj G; Clenet M; Rousselet F
Ann Pharm Fr; 1986; 44(5):347-54. PubMed ID: 3579157
[No Abstract] [Full Text] [Related]
10. Effects of hypolipidemic drugs on hepatic CoA.
Halvorsen O
Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
[No Abstract] [Full Text] [Related]
11. Experimental studies on pharmacology, metabolism and toxicology with tiadenol-disulfoxide. Dissociation of lipid lowering effects and the induction of peroxisomal and microsomal drug-metabolizing enzymes.
Maffei Facino R; Carini M; Tofanetti O; Casciarri I; Longoni E
Arzneimittelforschung; 1987 Jun; 37(6):682-91. PubMed ID: 3663266
[TBL] [Abstract][Full Text] [Related]
12. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
Seki K; Fukuda M; Isegawa J; Ohki M
Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
[No Abstract] [Full Text] [Related]
13. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G
Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933
[TBL] [Abstract][Full Text] [Related]
14. Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
Schladt L; Hartmann R; Timms C; Strolin-Benedetti M; Dostert P; Wörner W; Oesch F
Biochem Pharmacol; 1987 Feb; 36(3):345-51. PubMed ID: 2880593
[TBL] [Abstract][Full Text] [Related]
15. Carboxylic metabolites of tiadenol as "proximate" inducers of hepatic peroxisomal beta-oxidation activity.
Maffei Facino R; Carini M; Tofanetti O
Pharmacol Res Commun; 1988 Apr; 20(4):265-76. PubMed ID: 3387457
[TBL] [Abstract][Full Text] [Related]
16. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
Orton TC; Parker GL
Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
[TBL] [Abstract][Full Text] [Related]
17. Influence of tiadenol, bis-(hydroxyethylthio)1,10-decane, on cholesterol metabolism in rats.
Kritchevsky D; Tepper SA; Czarnecki SK; Story JA
Pharmacol Res Commun; 1979 Nov; 11(10):861-7. PubMed ID: 538065
[No Abstract] [Full Text] [Related]
18. [Inducing effects of bis-hydroxyethylthio-1,10-decane (tiadenol) on hepatic microsomal enzymes of the rat].
Mounie J; Goudonnet H; Bereksi-Reguig K; Escousse A; Truchot R
J Pharmacol; 1983; 14(2):171-82. PubMed ID: 6408317
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of long-chain acyl-CoA hydrolase activity in peroxisomes and mitochondria of rat liver by peroxisomal proliferators.
Berge RK; Flatmark T; Osmundsen H
Eur J Biochem; 1984 Jun; 141(3):637-44. PubMed ID: 6146524
[TBL] [Abstract][Full Text] [Related]
20. Hepatic peroxisome proliferators induce morphologic transformation of Syrian hamster embryo cells, but not peroxisomal beta oxidation.
Sanner T; Mikalsen SO; Rivedal E
Prog Clin Biol Res; 1991; 369():77-89. PubMed ID: 1946545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
